|
Synonyms: ALXN-1720 | ALXN1720 | CON-9978 | Klygefa® | TPP-2511
Compound class:
Antibody
Comment: Gefurulimab (ALXN1720) is a bispecific VHH nanobody that binds complement component C5 (in the terminal complement cascade) and serum albumin [1]. It is designed to block enzymatic cleavage of C5 (into biologically active C5a and C5b fragments), and reduce inflammation. Binding to serum albumin extends the agent's systemic half-life and therapeutic window.
|
| Immunopharmacology Comments |
| Inhibition of C5 cleavage into biologically active C5a and C5b fragments is a clinically validated mechanism that is utilised for the control and suppression of complement-induced inflammatory responses. |